Growing community of inventors

Logan, UT, United States of America

Prabhu Prasad Mohapatra

Average Co-Inventor Count = 2.84

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 18

Prabhu Prasad MohapatraLaxminarayan Bhat (13 patents)Prabhu Prasad MohapatraKouacou Adiey (10 patents)Prabhu Prasad MohapatraSeema Rani Bhat (1 patent)Prabhu Prasad MohapatraSureshbabu Dadiboyena (1 patent)Prabhu Prasad MohapatraPrabhu Prasad Mohapatra (13 patents)Laxminarayan BhatLaxminarayan Bhat (39 patents)Kouacou AdieyKouacou Adiey (15 patents)Seema Rani BhatSeema Rani Bhat (17 patents)Sureshbabu DadiboyenaSureshbabu Dadiboyena (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Reviva Pharmaceuticals, Inc. (13 from 27 patents)


13 patents:

1. 9975862 - Arylpiperazine derivatives and methods of utilizing same

2. 9604944 - Arylpiperazine derivatives and methods of utilizing same

3. 9255076 - Arylpiperazine derivatives and methods of utilizing same

4. 8980883 - Arylpiperazine derivatives and methods of utilizing same

5. 8859552 - Methods of utilizing arylpiperazine derivatives

6. 8580822 - Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

7. 8575185 - Compositions, synthesis, and methods of utilizing quinazolinedione derivatives

8. 8461154 - Methods of utilizing arylpiperazine derivatives

9. 8431570 - Methods of utilizing arylpiperazine derivatives

10. 8247563 - Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

11. 8247420 - Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents

12. 8207163 - Compositions, synthesis, and methods of using piperazine based antipsychotic agents

13. 8188076 - Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…